top of page
Homepage Banner Ibex Biosciences 10

Ibex Biosciences, INC ("Ibex") is headquartered in North Bethesda, Maryland. Unusual for early-stage biotechnology companies, Ibex engages in a diverse approach to research and development.

Ibex strives to discover, validate, and produce potential solutions to a multitude of serious challenges facing human health by investing in exploratory projects and processes that may not have been validated within the public research community. 

Ibex's mission is the relentless pursuit to effectively treat unmet medical conditions plaguing humanity.

Research & Development

Ibex has a portfolio of therapeutic antibodies, gene therapies and regeneration programs. Additionally, Ibex is developing a diagnostic to increase the reliability of biopsies.

Latest News 
patent photo.jpg

Ibex Announces New Patent Pending

July 14, 2022

Ibex announces the patent publication of Antibodies targeted to CD147

Ibex Biosciences awarded as a Top 10 Biotech Startup of 2022

bottom of page